September 20, 2005
Zidovudine oral solution, a generic version of a child-friendly HIV/AIDS drug, has received tentative approval from the Food and Drug Administration. FDA's action means that while existing patents or exclusivity agreements prevent the product's marketing within the United States, the drug meets the agency's standards for quality, safety and effectiveness. In addition, the decision means the drug can now be made available for use outside the United States through the President's Emergency Plan for AIDS Relief. For more information, visit www.fda.gov/bbs/topics/news/2005/new01230.html.
Newsday (New York)
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.